SURF Annual CFI
$22.76 M
+$122.01 M+122.93%
31 December 2022
Summary:
As of February 5, 2025, SURF annual cash flow from investing activities is $22.76 million, with the most recent change of +$122.01 million (+122.93%) on December 31, 2022. During the last 3 years, it has risen by +$5.79 million (+34.14%).SURF Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SURF Quarterly CFI
$32.07 M
+$30.64 M+2136.47%
30 June 2023
Summary:
As of February 5, 2025, SURF quarterly cash flow from investing activities is $32.07 million, with the most recent change of +$30.64 million (+2136.47%) on June 30, 2023. Over the past year, it has increased by +$29.63 million (+1212.23%).SURF Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SURF TTM CFI
$41.35 M
+$29.63 M+252.66%
30 June 2023
Summary:
As of February 5, 2025, SURF TTM cash flow from investing activities is $41.35 million, with the most recent change of +$29.63 million (+252.66%) on June 30, 2023. Over the past year, it has increased by +$44.38 million (+1463.89%).SURF TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SURF Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +122.9% | +1212.2% | +1463.9% |
| 3 y3 years | +34.1% | +126.7% | -40.0% |
| 5 y5 years | -12.2% | +132.0% | +143.8% |
SURF Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -61.0% | -41.7% | -41.0% |
Surface Oncology Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $32.07 M(+2136.5%) | $41.35 M(+252.7%) |
| Mar 2023 | - | $1.43 M(-80.9%) | $11.73 M(-48.5%) |
| Dec 2022 | $22.76 M(-122.9%) | $7.53 M(+2229.7%) | $22.76 M(+316.0%) |
| Sept 2022 | - | $323.00 K(-86.8%) | $5.47 M(-280.4%) |
| June 2022 | - | $2.44 M(-80.4%) | -$3.03 M(-81.2%) |
| Mar 2022 | - | $12.46 M(-227.7%) | -$16.15 M(-83.7%) |
| Dec 2021 | -$99.25 M(-270.2%) | -$9.76 M(+19.3%) | -$99.25 M(+14.7%) |
| Sept 2021 | - | -$8.18 M(-23.4%) | -$86.51 M(+39.6%) |
| June 2021 | - | -$10.68 M(-84.9%) | -$61.98 M(+66.8%) |
| Mar 2021 | - | -$70.63 M(-2471.1%) | -$37.15 M(-163.7%) |
| Dec 2020 | $58.31 M | $2.98 M(-81.8%) | $58.31 M(-16.9%) |
| Sept 2020 | - | $16.35 M(+15.6%) | $70.14 M(+1.7%) |
| June 2020 | - | $14.15 M(-43.0%) | $68.94 M(+5.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $24.83 M(+67.7%) | $65.29 M(+284.9%) |
| Dec 2019 | $16.96 M(-146.4%) | $14.81 M(-2.3%) | $16.96 M(-70.3%) |
| Sept 2019 | - | $15.15 M(+44.2%) | $57.14 M(+27.2%) |
| June 2019 | - | $10.51 M(-144.7%) | $44.93 M(-168.3%) |
| Mar 2019 | - | -$23.50 M(-142.7%) | -$65.81 M(+79.9%) |
| Dec 2018 | -$36.58 M(-241.2%) | $54.98 M(+1764.3%) | -$36.58 M(-57.0%) |
| Sept 2018 | - | $2.95 M(-102.9%) | -$85.14 M(-0.8%) |
| June 2018 | - | -$100.23 M(-1852.3%) | -$85.85 M(-573.2%) |
| Mar 2018 | - | $5.72 M(-10.9%) | $18.14 M(-30.0%) |
| Dec 2017 | $25.92 M(-137.6%) | $6.42 M(+186.5%) | $25.92 M(+32.9%) |
| Sept 2017 | - | $2.24 M(-40.3%) | $19.50 M(+13.0%) |
| June 2017 | - | $3.76 M(-72.2%) | $17.25 M(+27.8%) |
| Mar 2017 | - | $13.50 M | $13.50 M |
| Dec 2016 | -$68.97 M | - | - |
FAQ
- What is Surface Oncology annual cash flow from investing activities?
- What is the all time high annual CFI for Surface Oncology?
- What is Surface Oncology annual CFI year-on-year change?
- What is Surface Oncology quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Surface Oncology?
- What is Surface Oncology quarterly CFI year-on-year change?
- What is Surface Oncology TTM cash flow from investing activities?
- What is the all time high TTM CFI for Surface Oncology?
- What is Surface Oncology TTM CFI year-on-year change?
What is Surface Oncology annual cash flow from investing activities?
The current annual CFI of SURF is $22.76 M
What is the all time high annual CFI for Surface Oncology?
Surface Oncology all-time high annual cash flow from investing activities is $58.31 M
What is Surface Oncology annual CFI year-on-year change?
Over the past year, SURF annual cash flow from investing activities has changed by +$122.01 M (+122.93%)
What is Surface Oncology quarterly cash flow from investing activities?
The current quarterly CFI of SURF is $32.07 M
What is the all time high quarterly CFI for Surface Oncology?
Surface Oncology all-time high quarterly cash flow from investing activities is $54.98 M
What is Surface Oncology quarterly CFI year-on-year change?
Over the past year, SURF quarterly cash flow from investing activities has changed by +$29.63 M (+1212.23%)
What is Surface Oncology TTM cash flow from investing activities?
The current TTM CFI of SURF is $41.35 M
What is the all time high TTM CFI for Surface Oncology?
Surface Oncology all-time high TTM cash flow from investing activities is $70.14 M
What is Surface Oncology TTM CFI year-on-year change?
Over the past year, SURF TTM cash flow from investing activities has changed by +$44.38 M (+1463.89%)